| Loss Per Share |
Loss Per Share The details of the computation of basic and diluted loss per share are as follows: | | | | | | | | | | | | | | | | | | Successor | Predecessor | | | | (in millions of U.S. Dollars, except share data) | Period from September 30, 2025 to December 28, 2025 | September 29, 2025 | Three months ended December 29, 2024 | | | | | | Net (loss) income | $ | (150.6) | | $ | 1,063.8 | | $ | (372.2) | | | | | | | | | | | | | | | Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in thousands) | 26,057 | | 156,185 | | 129,018 | | | | | | | Net income (loss) per share attributable to common stockholders, basic | (5.78) | | 6.81 | | (2.88) | | | | | | | | | | | | | | | Net income (loss) attributable to common stockholders, diluted | (150.6) | | 1,063.8 | | (372.2) | | | | | | | | | | | | | | | Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in thousands) | 26,057 | | 156,185 | | 129,018 | | | | | | | Weighted-average effect of potentially dilutive securities: | | | | | | | | | RSUs (Successor) | — | | — | | — | | | | | | | 2L Convertible Notes | — | | — | | — | | | | | | 1.75% Convertible Notes | — | | 12,152 | | — | | | | | | 0.25% Convertible Notes | — | | 5,895 | | — | | | | | | 1.875% Convertible Notes | — | | 14,721 | | — | | | | | | | RSUs (Predecessor) | — | | 9 | | — | | | | | | | Weighted-average number of shares outstanding used to compute net income (loss) per share attributable to common stockholders, diluted (in thousands) | 26,057 | | 188,962 | | 129,018 | | | | | | | | | | | | | | | Net income (loss) per share attributable to common stockholders, diluted | $ | (5.78) | | $ | 5.63 | | $ | (2.88) | | | | | |
| | | | | | | | | | | | | | Successor | Predecessor | | (in millions of U.S. Dollars, except share data) | Period from September 30, 2025 to December 28, 2025 | Period from June 30, 2025 to September 29, 2025 | Six months ended December 29, 2024 | | Net (loss) income | $ | (150.6) | | $ | 420.2 | | $ | (654.4) | | | | | | | Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in thousands) | 26,057 | | 156,185 | | 127,876 | | | Net income (loss) per share attributable to common stockholders, basic | (5.78) | | 2.69 | (5.12) | | | | | | | Net income (loss) attributable to common stockholders, diluted | (150.6) | | 420.2 | | (654.4) | | | | | | | Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in thousands) | 26,057 | | 156,185 | | 127,876 | | | Weighted-average effect of potentially dilutive securities: | | | | | RSUs (Successor) | — | | — | | — | | | 2L Convertible Notes | — | | — | | — | | 1.75% Convertible Notes | — | | 12,152 | | — | | 0.25% Convertible Notes | — | | 5,895 | | — | | 1.875% Convertible Notes | — | | 14,721 | | — | | | RSUs (Predecessor) | — | | 99 | | — | | | Weighted-average number of shares outstanding used to compute net income (loss) per share attributable to common stockholders, diluted (in thousands) | 26,057 | | 189,052 | | 127,876 | | | | | | | Net income (loss) per share attributable to common stockholders, diluted | $ | (5.78) | | $ | 2.22 | | $ | (5.12) | |
Diluted net loss per share is the same as basic net loss per share for the periods presented due to potentially dilutive items being anti-dilutive given the Company's net loss. For the period of September 29, 2025, the period from June 30, 2025 to September 29, 2025 and the period from September 30, 2025 to December 28, 2025, 0.0 million, 0.0 million and 63.2 million of weighted average shares, respectively, were excluded from the calculation of diluted loss per share because their effect would be anti-dilutive. For the three and six months ended December 29, 2024, 9.5 million and 9.2 million of weighted average shares, respectively, were excluded from the calculation of diluted loss per share because their effect would be anti-dilutive. For periods subsequent to the receipt of the Regulatory Approvals, the Company will calculate the dilutive impact of the New 2L Renesas Convertible Notes on earnings per share using the if-converted method, if dilutive. The New 2L Renesas Convertibles Notes will be reflected in the calculation of diluted earnings per share using the if-converted method. Refer to Note 2, "Emergence from Voluntary Reorganization Under Chapter 11" and Note 3, "Fresh Start Accounting" for additional discussion regarding additional dilution related to the receipt of Regulatory Approvals. |